CPT® Code 68841

The procedure described by CPT® Code 68841 involves the insertion of a drug-eluting implant into the lacrimal canaliculus, which is a small duct that drains tears from the eye. This procedure may also include punctal dilation if necessary. The lacrimal canaliculus connects to the lacrimal puncta, located at the inner corners of each eye, where tears are collected from the lacrimal lake. The drug-eluting implant, often referred to as an intracanalicular plug, is made from an absorbable polyethylene glycol hydrogel that is infused with medication, such as dexamethasone or travoprost. Dexamethasone is typically used to manage postoperative inflammation and pain, while travoprost is indicated for the treatment of glaucoma and ocular hypertension. The implant is designed to provide a sustained release of the medication directly into the eye, allowing for effective treatment over time. As the medication is absorbed, it is gradually released into the ocular surface and subsequently exits through the nasolacrimal system. After the treatment period, the implant is expected to be fully absorbed by the body. Additionally, the implant contains a visualization agent that assists in monitoring its retention and can facilitate removal if needed before the treatment course is completed. This code should be reported for the insertion of each individual implant performed during the procedure.